Guilin Sanjin Pharmaceutical Co Ltd (002275) — Cash Flow-to-Debt Ratio
Guilin Sanjin Pharmaceutical Co Ltd (002275) has a Cash Flow-to-Debt Ratio of 0.11x as of September 2025, meaning its operating cash flow of CN¥117.62 Million could theoretically repay 0% of its total liabilities (CN¥1.05 Billion) in one year. Explore 002275 long-term investments to assets to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Guilin Sanjin Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2006–2024)
Historical debt coverage capacity for Guilin Sanjin Pharmaceutical Co Ltd across 19 annual periods. Also explore balance sheet size of Guilin Sanjin Pharmaceutical Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Guilin Sanjin Pharmaceutical Co Ltd (2006–2024)
Year-by-year debt coverage analysis for Guilin Sanjin Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see market value of Guilin Sanjin Pharmaceutical Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.48x | CN¥588.33 Million | CN¥1.22 Billion | ▼ -1.9% |
| 2023 | 0.49x | CN¥549.25 Million | CN¥1.12 Billion | ▲ +6.9% |
| 2022 | 0.46x | CN¥528.67 Million | CN¥1.15 Billion | ▲ +40.6% |
| 2021 | 0.33x | CN¥410.24 Million | CN¥1.26 Billion | ▼ -49.6% |
| 2020 | 0.65x | CN¥597.99 Million | CN¥923.27 Million | ▼ -17.0% |
| 2019 | 0.78x | CN¥468.29 Million | CN¥600.18 Million | ▼ -15.2% |
| 2018 | 0.92x | CN¥551.73 Million | CN¥599.47 Million | ▲ +36.6% |
| 2017 | 0.67x | CN¥387.82 Million | CN¥575.65 Million | ▼ -44.2% |
| 2016 | 1.21x | CN¥536.85 Million | CN¥444.26 Million | ▲ +26.3% |
| 2015 | 0.96x | CN¥398.50 Million | CN¥416.59 Million | ▲ +11.7% |
| 2014 | 0.86x | CN¥396.53 Million | CN¥463.07 Million | ▲ +32.5% |
| 2013 | 0.65x | CN¥314.16 Million | CN¥486.11 Million | ▼ -13.0% |
| 2012 | 0.74x | CN¥302.59 Million | CN¥407.26 Million | ▼ -52.5% |
| 2011 | 1.56x | CN¥341.05 Million | CN¥218.18 Million | ▼ -0.6% |
| 2010 | 1.57x | CN¥285.49 Million | CN¥181.47 Million | ▲ +20.8% |
| 2009 | 1.30x | CN¥363.29 Million | CN¥279.00 Million | ▲ +158.2% |
| 2008 | 0.50x | CN¥190.97 Million | CN¥378.65 Million | ▲ +7.2% |
| 2007 | 0.47x | CN¥164.39 Million | CN¥349.58 Million | ▼ -55.8% |
| 2006 | 1.06x | CN¥217.67 Million | CN¥204.48 Million | — |